维普中文期刊产品整合服务
21篇 您的检索式:作者名="Martin Michaelis"
    题名 作者 年代 出处 被引量
1Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates显示文摘Dear Editor,Omicron(B.1.1.529),is a heavily mutated and highly contagious SARS-CoV-2 variant,which is currently causing large outbreaks in many countries.Protection provided by current vaccines is substantially reduced against Omicron.1,2 Moreover,many immunocompromised individuals cannot effectively be protected by vaccines.3 Hence,antiviral therapies will be essential to protect the most vulnerable individuals from severe COVID-19.Denisa Bojkova Marek Widera Sandra Ciesek Mark N.Wass Martin Michaelis Jindrich Cinatl Jr 2022Cell Research2022,32,3:10
2Induction of apoptosis by curcumin: mediation by glutathione S -transferase P1-1 inhibition显示文摘Annelyse Duvoix Franck Morceau Sylvie Delhalle Martine Schmitz Micha?l Schnekenburger Marie-Madeleine Galteau Mario Dicato Marc Diederich 2003Biochemical Pharmacology2003,,8:2
3Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus显示文摘 Lidia Baltina Martin Michaelis 2005J Med Chem2005,48,:1
4Some recent trends in research and technology of advanced thermal barrier coatings显示文摘Uwe Schulz Christoph Leyens Klaus Fritscher Manfred Peters Bilge Saruhan-Brings Odile Lavigne Jean-Marc Dorvaux Martine Poulain Remy Mévrel Micha?l Caliez 2002Aerospace Science and Technology2002,,1:1
5A sensory neuron–expressed IL-31 receptor mediates T helper cell–dependent itch: Involvement of TRPV1 and TRPA1显示文摘Ferda Cevikbas Xidao Wang Tasuku Akiyama Cordula Kempkes Terhi Savinko Attila Antal Gabriela Kukova Timo Buhl Akihiko Ikoma Joerg Buddenkotte Vassili Soumelis Micha Feld Harri Alenius Stacey R. Dillon Earl Carstens Bernhard Homey Allan Basbaum Martin Stei 2013The Journal of Allergy and Clinical Immunology2013,,:1
6Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells显示文摘Henry Ogbomo Martin Michaelis Janina Geiler Marijke Rikxoort Thomas Muster Andrej Egorov Hans Wilhelm Doerr Jindrich Cinatl 2010Medical Microbiology and Immunology2010,,2:1
7N-acetyl- l -cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus显示文摘Janina Geiler Martin Michaelis Patrizia Naczk Anke Leutz Klaus Langer Hans-Wilhelm Doerr Jindrich Cinatl 2009Biochemical Pharmacology2009,,3:1
8Isolation and character- ization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae显示文摘Michaeli T Bloom T J Martins T 1993J Biol Chem1993,268,12:1
9Differential antiviral and anti-inflammatory mechanisms of the flavo- noids biochanin A and baicalein in H5NI influenza A virus-infected cells显示文摘Patchima Sithisarn Martin Michaelis Manfred Schubert-Zsilavecz 2013Antiviral Research2013,97,1:1
10Environmental Applications of Semiconducter Photocatalysis显示文摘Michae R H Martin S T Choi W Y 1995Chem Rev1995,95,:1
11Toona sinensis Roem tender leaf Extract inhibits SARS coronavirus replication 显示文摘Chung-Jen Chen Martin Michaelis Hseng-Kuang Hsu 2008Journal of Ethnopharmacolo- gy2008,120,:1
12Drug-adapted cancer cell lines as preclinical models of acquired resistance显示文摘Acquired resistance formation limits the efficacy of anti-cancer therapies.Acquired and intrinsic resistance differ conceptually.Acquired resistance is the consequence of directed evolution,whereas intrinsic resistance depends on the(stochastic)presence of pre-existing resistance mechanisms.Preclinical model systems are needed to study acquired drug resistance because they enable:(1)in depth functional studies;(2)the investigation of non-standard treatments for a certain disease condition(which is necessary to identify small groups of responders);and(3)the comparison of multiple therapies in the same system.Hence,they complement data derived from clinical trials and clinical specimens,including liquid biopsies.Many groups have successfully used drug-adapted cancer cell lines to identify and elucidate clinically relevant resistance mechanisms to targeted and cytotoxic anti-cancer drugs.Hence,we argue that drug-adapted cancer cell lines represent a preclinical model system in their own right that is complementary to other preclinical model systems and clinical data.Martin Michaelis Mark N.Wass Jindrich Cinatl jr 2019Cancer Drug Resistance2019,2,3:1
13Evaluation of acid gelling agents for use in well stimulation显示文摘Crowe C W Martin R C Michaelis A M 1981JPT1981,,:1
14Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baiealein in H5N1 influenza A virus-infected cellsOriginal Research Article显示文摘Patehima Sithisarn Martin Michaelis Manfred Schubert-Zsilavecz 2013AntiviralResearch2013,97,1:1
15Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase deficient Saccharomyces cerevisiae 显示文摘Michaeli T Bloom T J Martins T 1993J Biol Chem1993,268,12:1
16Thoracic and abdominal MRA with gadofosveset: Influence of injection rate on vessel signal and image quality显示文摘Johanna C. Nissen Ulrike I. Attenberger Christian Fink Olaf Dietrich Martin Rohrer Stefan O. Schoenberg Henrik J. Michaely 2009European Radiology2009,,8:1
17Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells显示文摘Karsten Ulbrich Martin Michaelis Florian Rothweiler Thomas Knobloch Patchima Sithisarn Jindrich Cinatl J?rg Kreuter 2011International Journal of Pharmaceutics2011,,1:1
18Dyes in Carbon Nanotube Arrays显示文摘Gerhard Lackner Tobias Mayer-Uhma Ingolf Endler Richard Boucher Frank Meissner Sebastian Scholz Mario Krug Viktor Bezugly Martin Mkandawire Anindya Majumder Daria A. Kovalenko Susan Conze Stefanie Hildebrandt Alexander Michaelis Doru C. Lupascu 2012材料科学与工程(中英文B版)2012,2,6:0
19Words apart:Standardizing forestry terms and definitions across European biodiversity studies显示文摘Forest biodiversity studies conducted across Europe use a multitude of forestry terms,often inconsistently.This hinders the comparability across studies and makes the assessment of the impacts of forest management on biodiversity highly context-dependent.Recent attempts to standardize forestry and stand description terminology mostly used a top-down approach that did not account for the perspectives and approaches of forest biodiversity experts.This work aims to establish common standards for silvicultural and vegetation definitions,creating a shared conceptual framework for a consistent study on the effects of forest management on biodiversity.We have identified both strengths and weaknesses of the silvicultural and vegetation information provided in forest biodiversity studies.While quantitative data on forest biomass and dominant tree species are frequently included,information on silvicultural activities and vegetation composition is often lacking,shallow,or based on broad and heterogeneous classifications.We discuss the existing classifications and their use in European forest biodiversity studies through a novel bottom-up and top-driven review process,and ultimately propose a common framework.This will enhance the comparability of forest biodiversity studies in Europe,and puts the basis for effective implementation and monitoring of sustainable forest management policies.The standards here proposed are potentially adaptable and applicable to other geographical areas and could be extended to other forest interventions.Giovanni Trentanovi Thomas Campagnaro Tommaso Sitzia Francesco Chianucci Giorgio Vacchiano Christian Ammer MichałCiach Thomas ANagel Miren del Río Yoan Paillet Silvana Munzi Kris Vandekerkhove Andrés Bravo-Oviedo Andrea Cutini Ettore D'Andrea Pallieter De Smedt Inken Doerfler Dimitris Fotakis Jacob Heilmann-Clausen Jeňýk Hofmeister Jan Hošek Philippe Janssen Sebastian Kepfer-Rojas Nathalie Korboulewsky Bence Kovács Daniel Kozák Thibault Lachat Anders Mårell Radim Matula Martin Mikoláš Björn Nordén PéterÓdor x Marko Perović Elisabeth Pötzelsberger Peter Schall Miroslav Svoboda Flóra Tinya Mariana Ujházyová Sabina Burrascano 2023Forest Ecosystems2023,10,4:0
20What really matters-response and resistance in cancer therapy显示文摘From 10th to 12th September of 2018,we held the first British Association of Cancer Research(BACR)Special Conference on“Response and Resistance in Cancer Therapy”at the University of Kent,Canterbury,UK.The conference theme is the subject of this Special Issue of Cancer Drug Resistance and we hope this editorial and the following contributions,will give you an insight into this important topic.Tim R.Fenton Michelle D.Garrett Mark N.Wass Martin Michaelis 2018Cancer Drug Resistance2018,1,4:0
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费